Hybio Pharmaceutical Co., Ltd. (SHE:300199)
China · Delayed Price · Currency is CNY 22.31
+0.58 (2.67%)
Jul 21, 2026, 3:05 PM CST
Hybio Pharmaceutical Revenue
Hybio Pharmaceutical had revenue of 299.15M CNY in the quarter ending March 31, 2026, a decrease of -3.49%. This brings the company's revenue in the last twelve months to 955.53M, up 27.42% year-over-year. In the year 2025, Hybio Pharmaceutical had annual revenue of 966.35M with 63.73% growth.
Revenue (ttm)
955.53M
Revenue Growth
+27.42%
P/S Ratio
20.62
Revenue / Employee
779.39K
Employees
1,226
Market Cap
19.71B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 966.35M | 376.15M | 63.73% |
| Dec 31, 2024 | 590.20M | 158.81M | 36.82% |
| Dec 31, 2023 | 431.38M | -272.94M | -38.75% |
| Jan 1, 2023 | 704.32M | -31.65M | -4.30% |
| Jan 1, 2022 | 735.97M | 14.25M | 1.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Revenue RankingsHybio Pharmaceutical News
- 21 days ago - US Food and Drug Administration to review Hybio's generic GLP-1s - Reuters